7x Winner of the MMIT Patient Choice Award!

Give us a call 855.726.8479 | 412.246.9858

PANTHERx Rare Pharmacy is proud to have again earned the #1 ranking in the quarterly patient satisfaction survey conducted by MMIT, an independent national survey entity. For the first quarter of 2021, PANTHERx obtained the highest Net Promoter Score (NPS) among all independent specialty pharmacies surveyed. Net Promoter Score (NPS) is compiled by asking patients, on a scale of 0 to 10, how likely they would be to recommend their specialty pharmacy to a friend or family member. With an NPS of 96 (out of 100), PANTHERx scored 37 points higher than the industry average.

“The opinions of our patients are of the utmost importance to PANTHERx, as we pride ourselves on providing superior services and white-glove care to our patients. The MMIT Specialty Pharmacy Patient Satisfaction surveys are a means by which we can quantitatively assess our performance and how we are perceived by the people we serve. Our consistently high rankings in this anonymous survey are an immense source of gratification for our company. To know that our patients are satisfied with our efforts brings greater meaning to the everyday job functions of our associates because we know that all of our actions, however small they may seem, are done in service of people living with rare diseases,” said Rob Snyder, President of PANTHERx Rare.

PANTHERx received perfect NPS scores from people living with Lambert-Eaton Myasthenic Syndrome, Hypophosphatasia, and Infantile Spasms amongst others.

The PANTHERx team is immeasurably honored to have earned such high marks from its patients, validating the company’s laser focus on rare disease and its dedication to providing white-glove patient care:

About PANTHERx Rare Pharmacy

PANTHERx Rare Pharmacy, now part of Centene’s Envolve Pharmacy Solutions, is one of the largest and fastest growing rare pharmacies in the United States. PANTHERx Rare transforms lives by delivering medicine breakthroughs, clinical excellence, and access solutions to patients afflicted with rare and devastating conditions. Although the incidence of rare disease is as common as diabetes, less than 7% of the 7,000 known rare and devastating disorders have an approved therapy. Changes in federal policy and advances in science have led to a surge in FDA orphan drug approvals, providing tremendous hope to the rare disease community.

PANTHERx was recently recognized as a Rare Disease Center of Excellence by URAC. PANTHERx was previously awarded Specialty Pharmacy of the Year by the National Association of Specialty Pharmacy (NASP) and earned the inaugural Accredited Distinction in Rare Diseases and Orphan Drugs from the Accreditation Commission for Health Care (ACHC). PANTHERx is a three-time winner of the prestigious MMIT Patient Choice Award, including the 2020 honor. PANTHERx is headquartered in Pittsburgh, Pennsylvania, licensed in all 50 states, and holds accreditations from URAC, NABP, and ACHC.